Indoor Biotechnologies is an immunodiagnostics and biotechnology company specializing in manufacturing innovative products for investigating allergy and asthma. The company is recognized as the world leader in assessment of environmental exposure to allergens - in the home, workplace, schools and commercial buildings. The company is at the forefront of research on allergen structure, molecular biology and immune response. Our mission is to improve the quality of life of patients with allergy and asthma.

About Us

Indoor Biotechnologies is privately held and organized as two affiliated companies, INDOOR Biotechnologies Inc. (IBI), located in Charlottesville, Virginia, USA, and INDOOR Biotechnologies Limited (IBL) based in Warminster, UK. IBI carries out research, development and sales in the Americas.  IBL handles sales, distribution and business development in Europe, the Far East, Australia and New Zealand.  Indoor Biotechnologies has a global presence, with authorized distributors in Japan, China, South Korea, Australia and New Zealand and sales in 35 different countries.  Indoor Biotechnologies is an entrepreneurial company that couples innovative science with a creative approach to business to add value through technology.

Indoor Biotechnologies core technology is a comprehensive, proprietary portfolio of antibodies for the detection of house dust mite, cat, dog, cockroach, mold, pollen and food allergens.  These antibodies are key components in assay platforms including ELISA and MARIA­­ technology for allergen detection and our Ventia rapid allergen test.

Indoor Biotechnologies has a complete range of tests for assessing environmental exposure to indoor allergens; for testing the efficacy of allergen avoidance procedures, products and devices, for allergen standardization and for new product development.

Indoor Biotechnologies also manufactures purified natural and recombinant allergens for research use and for development of allergy diagnostics and vaccines. This product line currently includes fifty purified allergens that are manufactured to a high degree of purity and biologic activity.  The line includes purified LoTox allergens with low endotoxin content that are designed for immunologic studies of allergy and asthma.

Our Mission

Indoor Biotechnologies is an immunodiagnostics and biotechnology company specializing in manufacturing innovative products for investigating allergy and asthma. The company is recognized as the world leader in assessment of environmental exposure to allergens - in the home, workplace, schools and commercial buildings. The company is also at the forefront of research on allergen structure, molecular biology and immune response. Our mission is to improve the quality of life of patients with allergy and asthma.

Indoor Biotechnologies is privately held and organized as two affiliated companies, INDOOR Biotechnologies Inc. (IBI), located in Charlottesville, Virginia, USA, and INDOOR Biotechnologies Limited (IBL) based in Warminster, UK. IBI carries out research, development and sales in the Americas. IBL handles sales, distribution and business development in Europe, the Far East, Australia and New Zealand. Indoor Biotechnologies has a global presence, with authorized distributors in Japan, China, South Korea, Australia and New Zealand and sales in 35 different countries. Indoor Biotechnologies is an entrepreneurial company that couples innovative science with a creative approach to business to add value through technology.

Indoor Biotechnologies' core technology is a comprehensive, proprietary portfolio of antibodies for the detection of house dust mite, cat, dog, cockroach, mold, pollen and food allergens. These antibodies are key components in assay platforms including ELISA kits and MARIA technology for allergen detection and our Ventia Rapid Allergen Test.

Our History

IB was founded by Dr. Martin D. Chapman, formerly Professor of Medicine and Microbiology at the University of Virginia and a member of the UVA Asthma and Allergic Diseases Center. Dr. Chapman is a Fellow of the American Academy of Allergy, Asthma and Immunology and has served as a consultant to the U.S. National Institutes of Health, the Environmental Protection Agency, and several biotechnology and environmental products companies. IB is organized as two affiliated companies, INDOOR Biotechnologies Inc. (IBI), located in Charlottesville, Virginia, USA, and INDOOR Biotechnologies Limited (IBL) based in Warminster, UK. IBI carries out research, development and sales in the Americas and IBL handles sales, distribution and business development in Europe, the Far East, Australia and New Zealand.

FEATURED PRODUCTS

Maria - Multiplex Array For Indoor Allergens Kits

The State-of-the-Art in Allergen Detection: Simultaneous detection of multiple allergens in a single test. Provides improved assay performance (increased sensitivity, accuracy and precision) King EM et al. J Immunol Methods. 2012. High throughput system, with substantial time and cost savings. Combines the power of Indoor Biotechnologies’ proprietary antibodies with Luminex xMAP technology.

CAT K3-350-040 - FITkit Hev b 5

Instructions for use of FITkit Hev b 5 in quantitative determination of Hev b 5 in natural rubber latex products

FEATURED SERVICES

Environmental Testing

Environmental testing services have been established at Indoor Biotechnologies for over 10 years. Our clients include the U.S. Centers for Disease Control (CDC), the National Institute for Occupational Safety and Hygiene (NIOSH), Department of Housing and Urban Development (HUD), as well as National Institutes of Health funded studies at leading academic medical centers. In Europe, we have analyzed samples in the EU CREATE project and in EUROPREVALL. ...

FEATURED DOWNLOADS

EVENTS ATTENDED

American Industrial Hygiene Conference and Expo (AIHce 2012)

Company details

Business Type:
Technology - Manufacturer

Industry Type:
Health and Safety - Workplace Safety

Market Focus:
Globally (various continents)

ShareThis

Environmental Expert is part of XPRT Media All Rights Reserved